RESUMO
PURPOSE: The HOLA COVID-19 study sought to evaluate the impact of COVID-19 on oncology practices across Latin America (LATAM), challenges faced by physicians, and how practices and physicians adapted while delivering care to patients with cancer. METHODS: This international cross-sectional study of oncology physicians in LATAM included a 43-item anonymous online survey to evaluate changes and adaptations to clinical practice. Multivariable logistic regression analyses were used to evaluate the association of caring for patients with COVID-19 and changes to clinical practice. RESULTS: A total of 704 oncology physicians from 19 countries completed the survey. Among respondents, the most common specialty was general oncology (34%) and 56% of physicians had cared for patients with COVID-19. The majority of physicians (70%) noted a decrease in the number of new patients evaluated during the COVID-19 pandemic when compared with prepandemic, and 73% reported adopting the use of telemedicine in their practice. More than half (58%) of physicians reported making changes to the treatments that they offered to patients with cancer. In adjusted models, physicians who had cared for patients with COVID-19 had higher odds of changing the type of chemotherapy or treatments that they offered (adjusted odds ratio 1.81; 95% CI, 1.30 to 2.53) and of delaying chemotherapy start (adjusted odds ratio 2.05; 95% CI, 1.49 to 2.81). Physicians identified significant delays in access to radiation and surgical services, diagnostic tests, and supportive care. CONCLUSION: The COVID-19 pandemic has significantly disrupted global cancer care. Although changes to health care delivery are a necessary response to this global crisis, our study highlights the significant disruption and changes to the treatment plans of patients with cancer in LATAM resulting from the COVID-19 health care crisis.
Assuntos
COVID-19 , Neoplasias , Estudos Transversais , Atenção à Saúde , Humanos , América Latina/epidemiologia , Neoplasias/terapia , Pandemias , Assistência ao Paciente , SARS-CoV-2RESUMO
Introducción: La reconstrucción mamaria es parte fundamental del tratamiento de la mujer mastectomizada por cáncer de mama. Tras comprobarse que la reconstrucción no influye negativamente sobre la enfermedad neoplásica, sino que es trascendental para la rehabilitación física y psicológica de la paciente, su desarrollo se ha visto favorecido. Materiales y métodos: Se realizó un estudio de tipo prospectivo, observacional, descriptivo y comparativo tipo ensayo clínico, entre los colgajos miocutáneos TRAM y dorsal ancho ampliado, en las pacientes sometidas a cirugía electiva. Resultados: Se incluyó un total de 36 pacientes, dividiéndose en 2 grupos de 20 pacientes para el grupo TRAM y 16 para el grupo de dorsal ampliado, con una edad promedio de 45,45 ± 9,50 años en el TRAM y de 56,09 ± 9,07 años en el de dorsal ampliado, con un IMC que oscilaba en ambos grupos entre 25,0-29,9. Se realizó en 19 pacientes mastectomía radical modificada tipo Madden + TRAM, representando un 80%, donde se simetrizó el 15% de dicho grupo. Se realizó un Halsted + TRAM bipediculado, representando un 5%; al grupo dorsal se les realizó mastectomía radical modificada tipo Madden, simetrizándose el 31,3%. Respecto a las complicaciones, se observó en general que en las pacientes del grupo TRAM predominaron la infección de la herida operatoria y la necrosis, con un 25,0% cada una, seguidas de seroma y dehiscencia de sutura con un 10% cada una, describiéndose solo un caso de eventración, totalizando 11 pacientes, donde 3 presentaron 2 o más complicaciones de las descritas anteriormente asociadas; en el grupo de dorsal ampliado predominaron los seromas, con un 18,8%, y necrosis en un 12,5%, totalizando 4 pacientes, igualmente una con 2 complicaciones asociadas. Conclusiones: La reconstrucción mamaria posterior a la Mastectomía con sus diferentes técnicas representa un procedimiento seguro y que se debe implementar en todos los centros en que se manejen pacientes con cáncer de mama, como en nuestro servicio de Cirugía Oncológica.
Introduction: Breast reconstruction is a fundamental part of the treatment of women with mastectomies. After finding that rebuilding a negative effect on the neoplastic disease, but is critical to the physical and psychological rehabilitation of the patient, its development has been favored. Selecting the right process depends on multiple factors such as patient age, stage of disease, smoking, obesity, adjuvant treatment, experience and technical capacity of the center where they will perform the reconstruction, among other. Materials and methods: A study of prospective, observational, descriptive and comparative clinical trial type was held between myocutaneous flaps extended dorsal and TRAM, in patients undergoing elective surgery. Results: A total of 36 patients were included, divided into 2 groups of 20 patients TRAM group and 16 expanded dorsal group, with a mean age of 45.45 ± 9,50 years old in the TRAM and the expanded dorsal group of 56.09 ± 9.07 years old with a BMI in both groups ranged between 25.0-29.9. They were performed in 19 patients radical modified mastectomy Madden + TRAM type representing 80%, where 15% of this group symmetrize. A Halsted + TRAM bipedicled was performed representing 5%; the dorsal group underwent modified radical mastectomy Madden 100%, symmetrize the 31.3%. Overall complications was observed in patients TRAM group predominated operative wound infection and necrosis with 25.0% each, followed by seroma and wound dehiscence with 10% each, describing only one hernia totaling 11 patients, where 3 patients had 2 or more complications associated previously described; in extended dorsal group seroma they predominated with 18.8% and 12.5% necrosis, totaling 4 patients alike with 2 associated complications. Conclusions: The post-mastectomy breast reconstruction with different techniques is a safe procedure that must be implemented in all centers where patients with breast cancer, and our service are handled Surgical Oncology.